Hyperfractionated accelerated radiotherapy (HART) for inoperable, nonmetastatic non-small cell lung carcinoma of the lung (NSCLC): results of a phase II study for patients ineligible for combination radiochemotherapy (Q73307130)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 December 1999

Language	Label	Description	Also known as
English	Hyperfractionated accelerated radiotherapy (HART) for inoperable, nonmetastatic non-small cell lung carcinoma of the lung (NSCLC): results of a phase II study for patients ineligible for combination radiochemotherapy	scientific article published on 01 December 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Hyperfractionated accelerated radiotherapy (HART) for inoperable, nonmetastatic non-small cell lung carcinoma of the lung (NSCLC): results of a phase II study for patients ineligible for combination radiochemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

author name string

S Koutaïssoff

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Wellmann

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Coucke

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Ozsahin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Pampallona

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R O Mirimanoff

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1151-1156

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Therapeutic options for regionally advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival of patients with unresectable non-small-cell bronchogenic carcinoma by an innovated high-doseEn-Bloc radiotherapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensity of neoadjuvant therapy in resectable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant (induction) treatment for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemotherapy (CT) and radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC): a review

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial experience with a practical hyperfractionated accelerated radiotherapy regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: unusual toxicity and promising early results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated accelerated radiation therapy for non-small cell lung cancer: clinical phase I/II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapidly alternating combination of cisplatin-based chemotherapy and hyperfractionated accelerated radiotherapy in split course for stage IIIA and stage IIIB non-small cell lung cancer: results of a phase I-II study by the GOTHA group. Group d'Oncolo

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 GY by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological basis of radiation therapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor doubling time and prognostic assessment of patients with primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Actual growth rate and tumour cell proliferation in human pulmonary neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the Radiation Therapy Oncology Group (RTOG 83-12): long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(99)00307-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73307130&oldid=2216445386"